204 related articles for article (PubMed ID: 23829359)
1. Neuroimaging studies of acute effects of THC and CBD in humans and animals: a systematic review.
Batalla A; Crippa JA; Busatto GF; Guimaraes FS; Zuardi AW; Valverde O; Atakan Z; McGuire PK; Bhattacharyya S; Martín-Santos R
Curr Pharm Des; 2014; 20(13):2168-85. PubMed ID: 23829359
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings.
Batalla A; Bhattacharyya S; Yücel M; Fusar-Poli P; Crippa JA; Nogué S; Torrens M; Pujol J; Farré M; Martin-Santos R
PLoS One; 2013; 8(2):e55821. PubMed ID: 23390554
[TBL] [Abstract][Full Text] [Related]
3. The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ
Gunasekera B; Davies C; Martin-Santos R; Bhattacharyya S
Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):636-645. PubMed ID: 33414100
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Cannabidiol on Human Brain Function: A Systematic Review.
Batalla A; Bos J; Postma A; Bossong MG
Front Pharmacol; 2020; 11():618184. PubMed ID: 33551817
[No Abstract] [Full Text] [Related]
5. Neuroimaging in cannabis use: a systematic review of the literature.
Martín-Santos R; Fagundo AB; Crippa JA; Atakan Z; Bhattacharyya S; Allen P; Fusar-Poli P; Borgwardt S; Seal M; Busatto GF; McGuire P
Psychol Med; 2010 Mar; 40(3):383-98. PubMed ID: 19627647
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoids, reward processing, and psychosis.
Gunasekera B; Diederen K; Bhattacharyya S
Psychopharmacology (Berl); 2022 May; 239(5):1157-1177. PubMed ID: 33644820
[TBL] [Abstract][Full Text] [Related]
7. Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure.
Colizzi M; McGuire P; Giampietro V; Williams S; Brammer M; Bhattacharyya S
Eur Neuropsychopharmacol; 2018 Jul; 28(7):850-862. PubMed ID: 29935939
[TBL] [Abstract][Full Text] [Related]
8. Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users.
Weinstein A; Livny A; Weizman A
Curr Pharm Des; 2016; 22(42):6366-6379. PubMed ID: 27549374
[TBL] [Abstract][Full Text] [Related]
9. Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy.
Allendorfer JB; Szaflarski JP
Epilepsy Behav; 2017 May; 70(Pt B):349-354. PubMed ID: 28109780
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive effects of cannabis: Lessons learned from human experimental studies.
Colizzi M; Bhattacharyya S
Prog Brain Res; 2018; 242():179-216. PubMed ID: 30471680
[TBL] [Abstract][Full Text] [Related]
11. Acute effects of ∆9-tetrahydrocannabinol (THC) on resting state brain function and their modulation by COMT genotype.
Bossong MG; van Hell HH; Schubart CD; van Saane W; Iseger TA; Jager G; van Osch MJP; Jansma JM; Kahn RS; Boks MP; Ramsey NF
Eur Neuropsychopharmacol; 2019 Jun; 29(6):766-776. PubMed ID: 30975584
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of neuroimaging and acute cannabis exposure in age-of-risk for psychosis.
Cupo L; Plitman E; Guma E; Chakravarty MM
Transl Psychiatry; 2021 Apr; 11(1):217. PubMed ID: 33850098
[TBL] [Abstract][Full Text] [Related]
13. Effects of cannabis on impulsivity: a systematic review of neuroimaging findings.
Wrege J; Schmidt A; Walter A; Smieskova R; Bendfeldt K; Radue EW; Lang UE; Borgwardt S
Curr Pharm Des; 2014; 20(13):2126-37. PubMed ID: 23829358
[TBL] [Abstract][Full Text] [Related]
14. Neural mechanisms for the cannabinoid modulation of cognition and affect in man: a critical review of neuroimaging studies.
Bhattacharyya S; Atakan Z; Martin-Santos R; Crippa JA; McGuire PK
Curr Pharm Des; 2012; 18(32):5045-54. PubMed ID: 22716136
[TBL] [Abstract][Full Text] [Related]
15. Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence.
Chye Y; Kirkham R; Lorenzetti V; McTavish E; Solowij N; Yücel M
Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):627-635. PubMed ID: 32948510
[TBL] [Abstract][Full Text] [Related]
16. Cannabis-associated psychosis: Neural substrate and clinical impact.
Murray RM; Englund A; Abi-Dargham A; Lewis DA; Di Forti M; Davies C; Sherif M; McGuire P; D'Souza DC
Neuropharmacology; 2017 Sep; 124():89-104. PubMed ID: 28634109
[TBL] [Abstract][Full Text] [Related]
17. The neuropsychopharmacology of cannabis: A review of human imaging studies.
Bloomfield MAP; Hindocha C; Green SF; Wall MB; Lees R; Petrilli K; Costello H; Ogunbiyi MO; Bossong MG; Freeman TP
Pharmacol Ther; 2019 Mar; 195():132-161. PubMed ID: 30347211
[TBL] [Abstract][Full Text] [Related]
18. Role of the endocannabinoid system in brain functions relevant for schizophrenia: an overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC).
Bossong MG; Jansma JM; Bhattacharyya S; Ramsey NF
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jul; 52():53-69. PubMed ID: 24380726
[TBL] [Abstract][Full Text] [Related]
19. Model-based analysis on systemic availability of co-administered cannabinoids after controlled vaporised administration.
Liu Z; Galettis P; Broyd SJ; van Hell H; Greenwood LM; de Krey P; Steigler A; Zhu X; Schneider J; Solowij N; Martin JH
Intern Med J; 2020 Jul; 50(7):846-853. PubMed ID: 31264294
[TBL] [Abstract][Full Text] [Related]
20. The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis.
Rabgay K; Waranuch N; Chaiyakunapruk N; Sawangjit R; Ingkaninan K; Dilokthornsakul P
J Am Pharm Assoc (2003); 2020; 60(1):225-234.e6. PubMed ID: 31495691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
